Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Natalie C. Holles currently holds 32,335 shares of Audentes Therapeutics, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Natalie C. Holles has been a net seller of BOLD stock. They have purchased $0 and sold $411.6K worth of shares.
Natalie C. Holles's most recent insider trade was on Aug 11, 2025, when they sold 1,218,836 shares at $0.00 per share.
Natalie C. Holles serves as Executive at Audentes Therapeutics, Inc. (BOLD). They have executed 30 insider transactions totaling $411.6K over their tenure at the company.
Natalie C. Holles holds the position of Executive at Audentes Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Natalie C. Holles has shown a selling trading pattern, with $0 in total purchases and $411.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Natalie C. Holles was on Jan 15, 2020, when they sold $6.3M worth of BOLD shares. This transaction involved 104,439 shares at $60.00 per share.
Natalie C. Holles currently owns 32,335 shares of Audentes Therapeutics, Inc. (BOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Natalie C. Holles's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Natalie C. Holles has 30 Form 4 filings on record as an insider at Audentes Therapeutics, Inc..
Set alerts for Natalie C. Holles and 40,000+ other insiders.